216 related articles for article (PubMed ID: 25143462)
21. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
Palinski W; Miller E; Witztum JL
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
[TBL] [Abstract][Full Text] [Related]
22. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
23. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.
Turunen SP; Kummu O; Harila K; Veneskoski M; Soliymani R; Baumann M; Pussinen PJ; Hörkkö S
PLoS One; 2012; 7(4):e34910. PubMed ID: 22496875
[TBL] [Abstract][Full Text] [Related]
24. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.
Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR
Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441
[TBL] [Abstract][Full Text] [Related]
25. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
26. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
Kummu O; Turunen SP; Wang C; Lehtimäki J; Veneskoski M; Kastarinen H; Koivula MK; Risteli J; Kesäniemi YA; Hörkkö S
Antioxid Redox Signal; 2013 Oct; 19(10):1047-62. PubMed ID: 23311771
[TBL] [Abstract][Full Text] [Related]
27. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.
Papac-Milicevic N; Busch CJ; Binder CJ
Adv Immunol; 2016; 131():1-59. PubMed ID: 27235680
[TBL] [Abstract][Full Text] [Related]
28. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL
PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319
[TBL] [Abstract][Full Text] [Related]
29. Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL.
Kyrklund M; Bildo M; Akhi R; Nissinen AE; Pussinen P; Hörkkö S; Wang C
PLoS One; 2020; 15(3):e0230682. PubMed ID: 32210456
[TBL] [Abstract][Full Text] [Related]
30. Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice.
Dimayuga PC; Zhao X; Yano J; Chyu KY
Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1644-50. PubMed ID: 16825416
[TBL] [Abstract][Full Text] [Related]
31. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J
Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338
[TBL] [Abstract][Full Text] [Related]
32. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
33. Vaccination against atherosclerosis? Induction of atheroprotective immunity.
Hansson GK; Nilsson J
Semin Immunopathol; 2009 Jun; 31(1):95-101. PubMed ID: 19468734
[TBL] [Abstract][Full Text] [Related]
34. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses.
Martos-Folgado I; Del Monte-Monge A; Lorenzo C; Busse CE; Delgado P; Mur SM; Cobos-Figueroa L; Escolà-Gil JC; Martín-Ventura JL; Wardemann H; Ramiro AR
Cell Rep; 2022 Oct; 41(2):111468. PubMed ID: 36223741
[TBL] [Abstract][Full Text] [Related]
35. Intracellular generation of MDA-LYS epitope in foam cells.
Huang GS; Wang ZP; Wang SC; Sun TJ; Chu R; Mao SJ
Life Sci; 1999; 65(3):285-96. PubMed ID: 10447214
[TBL] [Abstract][Full Text] [Related]
36. Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.
Amir S; Hartvigsen K; Gonen A; Leibundgut G; Que X; Jensen-Jarolim E; Wagner O; Tsimikas S; Witztum JL; Binder CJ
J Lipid Res; 2012 Jul; 53(7):1316-26. PubMed ID: 22508944
[TBL] [Abstract][Full Text] [Related]
37. Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.
Wigren M; Bengtsson D; Dunér P; Olofsson K; Björkbacka H; Bengtsson E; Fredrikson GN; Nilsson J
Circ Res; 2009 Jun; 104(12):e62-70. PubMed ID: 19478203
[TBL] [Abstract][Full Text] [Related]
38. Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.
Duryee MJ; Klassen LW; Jones BL; Willis MS; Tuma DJ; Thiele GM
Int Immunopharmacol; 2008 Aug; 8(8):1112-8. PubMed ID: 18550015
[TBL] [Abstract][Full Text] [Related]
39. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay.
Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ
Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579
[TBL] [Abstract][Full Text] [Related]
40. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
